Funding Round OverviewUpdate
- Eagan, MN
Cardiais an innovative company engaged in developing, manufacturing and marketing transcatheter septal occluders.
Incorporated in 1998, Cardia, Inc. is an innovative company engaged in developing, manufacturing and marketing transcatheter septal occluders. To date we have closed over 15,000 septal defects worldwide.
Ultrasept, our latest family of products, serves as our 7th generation of septal closure devices. The dual articulating sails allow for easy deployment of the devices and create a super low profile within the atria. Ultrasept devices boast a simple, hands-free loading feature and are fully retrievable before and after release. Ultrasept products include double-round devices for the percutaneous closure of both PFO’s (Patent Foramen Ovale) and ASD’s (Atrial Septal Defect).
A septal occluder is a cardiac implant that fixes a cardiac defect commonly referred to as a “hole in the heart." Our devices are delivered through a catheter by an interventional cardiologist and only take about 30 minutes to implant. Many... See More
Funding Rounds (4) - $4.30MUpdate
2900 Lone Oak Parkway
Eagan, MN 55121